Nicotinamide breakthrough could help cut A$500m skin cancer bill
A year of treatment with nicotinamide, a form of vitamin B3, significantly lowered the risk of common, non-melanoma skin cancer in high-risk patients, according to Australian research published in the New England Journal of Medicine.